Results 311 to 320 of about 4,732,777 (361)
Some of the next articles are maybe not open access.
Annals of Surgery, 2020
OBJECTIVE Carbohydrate antigen 19-9 (CA19-9) is a prognostic marker for patients with pancreatic cancer (PC), but its value as a treatment biomarker is unclear.
S. Tsai +13 more
semanticscholar +1 more source
OBJECTIVE Carbohydrate antigen 19-9 (CA19-9) is a prognostic marker for patients with pancreatic cancer (PC), but its value as a treatment biomarker is unclear.
S. Tsai +13 more
semanticscholar +1 more source
Seminars in Breast Disease, 2004
The modern era of neoadjuvant endocrine therapy was developed with tamoxifen in the 1980s. Trials showed useful downstaging to avoid mastectomy, but long term results showed that this could be used before but not instead of surgery. Recently neoadjuvant aromatase inhibitors have been shown to be superior to tamoxifen.
openaire +1 more source
The modern era of neoadjuvant endocrine therapy was developed with tamoxifen in the 1980s. Trials showed useful downstaging to avoid mastectomy, but long term results showed that this could be used before but not instead of surgery. Recently neoadjuvant aromatase inhibitors have been shown to be superior to tamoxifen.
openaire +1 more source
Neoadjuvant therapy in cancer treatment
Cancer, 1993Neoadjuvant therapy has come to play an increasingly prominent role in the treatment of cancer. Originally defined as systemic therapy given before local treatment, the concept has been extended to include radiation therapy given before surgery. Potential advantages include improved local and distant control, direct evaluation, and organ-sparing ...
E L, Trimble +7 more
openaire +2 more sources
Neoadjuvant Therapy for Gastric Cancer
Advances in Surgery, 2008Complete surgical resection remains the primary curative treatment option for patients with early stage gastric adenocarcinoma appropriately staged with an adequate lymphadenectomy. Unfortunately, only 40% patients who undergo curative resection at the authors' institution will have early stage (i.e., stage IA or T2N0M0) disease; thus, the majority of ...
Michael G, House, Murray F, Brennan
openaire +2 more sources
Neoadjuvant Therapy for Pancreatic Cancer
Journal of Gastrointestinal Surgery, 2008Surgical resection is necessary but generally insufficient as curative treatment for pancreatic cancer. Traditionally, postoperative (adjuvant) therapies have been utilized in an attempt to improve outcome, yet these efforts have met with extremely limited success.
openaire +2 more sources
NEOADJUVANT THERAPY OF ESOPHAGEAL CARCINOMA
Chest Surgery Clinics of North America, 1994To quote Steiger, the "multimodality treatment of esophageal cancer brings creativity and imagination to a field of medicine plagued with failure." However, acceptance of neoadjuvant chemotherapy or chemoradiotherapy as routine must await the results of large phase III studies. Even with a positive response, many questions will remain.
openaire +2 more sources
The cancer journal from Scientific American, 2006
A A, Forastiere, S G, Urba, W, Liggett
openaire +3 more sources
A A, Forastiere, S G, Urba, W, Liggett
openaire +3 more sources